ClinicalTrials.Veeva

Menu

Pain Management After Adductor Canal Block for Total Knee Arthroplasty

P

Poznan University of Medical Sciences (PUMS)

Status and phase

Completed
Phase 4

Conditions

Knee Arthritis
Knee Pain Chronic
Knee Osteoarthritis
Knee Arthropathy

Treatments

Drug: Ropivacaine 0.2% Injectable Solution
Drug: 0.9%sodium chloride

Study type

Interventional

Funder types

Other

Identifiers

NCT06086483
495/2020

Details and patient eligibility

About

This randomized, double-blinded, placebo-controlled trial sought to evaluate the efficacy of the iPACK block with Adductor Canal Block on postoperative pain, functional recovery and NLR and PLR levels.

Full description

The Interspace between the popliteal artery and capsule of the posterior knee, or iPACK block, together with the Adductor Canal block (ACB), has been described and shows promise in providing analgesia to the knee joint. However, the effect of these two blocks on postoperative pain levels, functional recovery, and stress response is uncertain. This study compares a preoperative iPACK and ACB block to Sham blocks before total knee arthroplasty under spinal anesthesia.

Enrollment

361 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients > 18 years old undergoing unilateral total knee arthroplasty

Exclusion criteria

  • refusal to participate
  • < 18 yo
  • Chronic opioid use
  • localized infection

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

361 participants in 2 patient groups

iPACK block+ABC block
Active Comparator group
Description:
Patients received a preoperative ultrasound-guided iPACK block with 20 mL of 0.25% ropivacaine and an Adductor Canal block with 20mL 0.25% ropivacaine.
Treatment:
Drug: Ropivacaine 0.2% Injectable Solution
Sham blocks
Active Comparator group
Description:
Patients received a preoperative ultrasound-guided iPACK block with 20 mL of 0.9% normal saline and an Adductor Canal block with 20mL 0.9% normal saline.
Treatment:
Drug: 0.9%sodium chloride

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems